The Food Drug Administration has rescinded its order to cancel Cipla Pharma's license and issued a fresh show-cause notice, reversing its stance after the Bombay High Court criticized the agency for exceeding its authority.

Regulatory authorities have cancelled the sales licence for Cipla's commercial facility handling controlled drugs in Pune following compliance violations.

U.S. regulators have revoked the operating license of Cipla’s Pune manufacturing facility and ordered a market recall after seizing unauthorized promotional materials and stock worth over ₹11 lakh.